| Product Code: ETC071145 | Publication Date: Jun 2023 | Updated Date: Sep 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
Malaysia is one of the countries that have seen an increase in demand for infectious disease biomarker testing. The country?s healthcare sector has been witnessing significant growth, with increased healthcare expenditure and infrastructure development which is driving the market potential. Government initiatives such as public-private partnerships are further strengthening the expansion of diagnostic laboratories for better diagnosis and treatment of infectious diseases. Furthermore, rising awareness among people regarding early detection and prevention of communicable diseases has boosted the utilization rate for biomarker tests in Malaysia. With increasing number of clinical trials being conducted to study new treatments related to infectious diseases, there is a huge potential for growth in this market over the forecast period (2020-2025). Major players operating in this space include Abbott Laboratories, Bio-Rad Laboratories Inc., DiaSorin SPA, Qiagen NV and Genomic Health Inc., among others
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Infectious Disease Biomarker Testing Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Infectious Disease Biomarker Testing Market Revenues & Volume, 2020 & 2027F |
3.3 Malaysia Infectious Disease Biomarker Testing Market - Industry Life Cycle |
3.4 Malaysia Infectious Disease Biomarker Testing Market - Porter's Five Forces |
3.5 Malaysia Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Product, 2020 & 2027F |
3.6 Malaysia Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Technology, 2020 & 2027F |
3.7 Malaysia Infectious Disease Biomarker Testing Market Revenues & Volume Share, By End-users, 2020 & 2027F |
4 Malaysia Infectious Disease Biomarker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Malaysia Infectious Disease Biomarker Testing Market Trends |
6 Malaysia Infectious Disease Biomarker Testing Market, By Types |
6.1 Malaysia Infectious Disease Biomarker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Infectious Disease Biomarker Testing Market Revenues & Volume, By Product, 2018 - 2027F |
6.1.3 Malaysia Infectious Disease Biomarker Testing Market Revenues & Volume, By Assays, Kits and Reagents, 2018 - 2027F |
6.1.4 Malaysia Infectious Disease Biomarker Testing Market Revenues & Volume, By Instruments, 2018 - 2027F |
6.1.5 Malaysia Infectious Disease Biomarker Testing Market Revenues & Volume, By Services and Software, 2018 - 2027F |
6.2 Malaysia Infectious Disease Biomarker Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Infectious Disease Biomarker Testing Market Revenues & Volume, By Immunodiagnostics, 2018 - 2027F |
6.2.3 Malaysia Infectious Disease Biomarker Testing Market Revenues & Volume, By Clinical Microbiology, 2018 - 2027F |
6.2.4 Malaysia Infectious Disease Biomarker Testing Market Revenues & Volume, By PCR, 2018 - 2027F |
6.2.5 Malaysia Infectious Disease Biomarker Testing Market Revenues & Volume, By INAAT, 2018 - 2027F |
6.2.6 Malaysia Infectious Disease Biomarker Testing Market Revenues & Volume, By DNA Sequencing and NGS, 2018 - 2027F |
6.2.7 Malaysia Infectious Disease Biomarker Testing Market Revenues & Volume, By Other Technologies, 2018 - 2027F |
6.3 Malaysia Infectious Disease Biomarker Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 Malaysia Infectious Disease Biomarker Testing Market Revenues & Volume, By Physician Offices, 2018 - 2027F |
6.3.3 Malaysia Infectious Disease Biomarker Testing Market Revenues & Volume, By Reference Laboratories, 2018 - 2027F |
6.3.4 Malaysia Infectious Disease Biomarker Testing Market Revenues & Volume, By Hospitals, 2018 - 2027F |
6.3.5 Malaysia Infectious Disease Biomarker Testing Market Revenues & Volume, By Academic and Research Institutes, 2018 - 2027F |
6.3.6 Malaysia Infectious Disease Biomarker Testing Market Revenues & Volume, By Others, 2018 - 2027F |
7 Malaysia Infectious Disease Biomarker Testing Market Import-Export Trade Statistics |
7.1 Malaysia Infectious Disease Biomarker Testing Market Export to Major Countries |
7.2 Malaysia Infectious Disease Biomarker Testing Market Imports from Major Countries |
8 Malaysia Infectious Disease Biomarker Testing Market Key Performance Indicators |
9 Malaysia Infectious Disease Biomarker Testing Market - Opportunity Assessment |
9.1 Malaysia Infectious Disease Biomarker Testing Market Opportunity Assessment, By Product, 2020 & 2027F |
9.2 Malaysia Infectious Disease Biomarker Testing Market Opportunity Assessment, By Technology, 2020 & 2027F |
9.3 Malaysia Infectious Disease Biomarker Testing Market Opportunity Assessment, By End-users, 2020 & 2027F |
10 Malaysia Infectious Disease Biomarker Testing Market - Competitive Landscape |
10.1 Malaysia Infectious Disease Biomarker Testing Market Revenue Share, By Companies, 2020 |
10.2 Malaysia Infectious Disease Biomarker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here